Global Drugs for Schistosomiasis Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2031

Report ID: 953381 | Published Date: Sep 2024 | No. of Page: 114 | Base Year: 2023 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Drugs for Schistosomiasis Product Introduction
    1.2 Market by Type
        1.2.1 Global Drugs for Schistosomiasis Market Size Growth Rate by Type
        1.2.2 Praziquantel
        1.2.3 Oxamniquine
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Drugs for Schistosomiasis Market Size Growth Rate by Application
        1.3.2 S. haematobium
        1.3.3 S. mansoni
        1.3.4 S. japonicum
        1.3.5 S. mekongi
        1.3.6 S. intercalatum
    1.4 Study Objectives
    1.5 Years Considered

2 Executive Summary
    2.1 Global Drugs for Schistosomiasis Market Size Estimates and Forecasts
        2.1.1 Global Drugs for Schistosomiasis Revenue 2016-2027
        2.1.2 Global Drugs for Schistosomiasis Sales 2016-2027
    2.2 Drugs for Schistosomiasis Market Size by Region: 2021 Versus 2027
    2.3 Drugs for Schistosomiasis Sales by Region (2016-2027)
        2.3.1 Global Drugs for Schistosomiasis Sales by Region: 2016-2021
        2.3.2 Global Drugs for Schistosomiasis Sales Forecast by Region (2022-2027)
        2.3.3 Global Drugs for Schistosomiasis Sales Market Share by Region (2016-2027)
    2.4 Drugs for Schistosomiasis Market Estimates and Projections by Region (2022-2027)
        2.4.1 Global Drugs for Schistosomiasis Revenue by Region: 2016-2021
        2.4.2 Global Drugs for Schistosomiasis Revenue Forecast by Region (2022-2027)
        2.4.3 Global Drugs for Schistosomiasis Revenue Market Share by Region (2016-2027)

3 Global Drugs for Schistosomiasis by Manufacturers
    3.1 Global Top Drugs for Schistosomiasis Manufacturers by Sales
        3.1.1 Global Drugs for Schistosomiasis Sales by Manufacturer (2016-2021)
        3.1.2 Global Drugs for Schistosomiasis Sales Market Share by Manufacturer (2016-2021)
    3.2 Global Top Drugs for Schistosomiasis Manufacturers by Revenue
        3.2.1 Global Drugs for Schistosomiasis Revenue by Manufacturer (2016-2021)
        3.2.2 Global Drugs for Schistosomiasis Revenue Share by Manufacturer (2016-2021)
    3.3 Global Drugs for Schistosomiasis Price by Manufacturer (2016-2021)
    3.4 Competitive Landscape
        3.4.1 Key Drugs for Schistosomiasis Manufacturers Covered: Ranking by Revenue
        3.4.2 Global Drugs for Schistosomiasis Market Concentration Ratio (CR5 and HHI) & (2016-2021)
        3.4.3 Global Drugs for Schistosomiasis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.5 Global Drugs for Schistosomiasis Manufacturing Base Distribution, Product Type
        3.5.1 Drugs for Schistosomiasis Manufacturers Manufacturing Base Distribution, Headquarters
        3.5.2 Manufacturers Drugs for Schistosomiasis Product Type
        3.5.3 Date of International Manufacturers Enter into Drugs for Schistosomiasis Market
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles
    4.1 Shin Poong
        4.1.1 Shin Poong Corporation Information
        4.1.2 Shin Poong Description, Business Overview
        4.1.3 Shin Poong Drugs for Schistosomiasis Products Offered
        4.1.4 Shin Poong Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2016-2021)
        4.1.5 Shin Poong Drugs for Schistosomiasis Revenue by Product
        4.1.6 Shin Poong Drugs for Schistosomiasis Revenue by Application
        4.1.7 Shin Poong Drugs for Schistosomiasis Revenue by Geographic Area
        4.1.8 Shin Poong Drugs for Schistosomiasis Revenue by Sales Channel
        4.1.9 Shin Poong Recent Development
    4.2 Merck
        4.2.1 Merck Corporation Information
        4.2.2 Merck Description, Business Overview
        4.2.3 Merck Drugs for Schistosomiasis Products Offered
        4.2.4 Merck Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2016-2021)
        4.2.5 Merck Drugs for Schistosomiasis Revenue by Product
        4.2.6 Merck Drugs for Schistosomiasis Revenue by Application
        4.2.7 Merck Drugs for Schistosomiasis Revenue by Geographic Area
        4.2.8 Merck Drugs for Schistosomiasis Revenue by Sales Channel
        4.2.9 Merck Recent Development
    4.3 Bayer
        4.3.1 Bayer Corporation Information
        4.3.2 Bayer Description, Business Overview
        4.3.3 Bayer Drugs for Schistosomiasis Products Offered
        4.3.4 Bayer Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2016-2021)
        4.3.5 Bayer Drugs for Schistosomiasis Revenue by Product
        4.3.6 Bayer Drugs for Schistosomiasis Revenue by Application
        4.3.7 Bayer Drugs for Schistosomiasis Revenue by Geographic Area
        4.3.8 Bayer Drugs for Schistosomiasis Revenue by Sales Channel
        4.3.9 Bayer Recent Development
    4.4 EIPICO
        4.4.1 EIPICO Corporation Information
        4.4.2 EIPICO Description, Business Overview
        4.4.3 EIPICO Drugs for Schistosomiasis Products Offered
        4.4.4 EIPICO Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2016-2021)
        4.4.5 EIPICO Drugs for Schistosomiasis Revenue by Product
        4.4.6 EIPICO Drugs for Schistosomiasis Revenue by Application
        4.4.7 EIPICO Drugs for Schistosomiasis Revenue by Geographic Area
        4.4.8 EIPICO Drugs for Schistosomiasis Revenue by Sales Channel
        4.4.9 EIPICO Recent Development
    4.5 Chandra Bhagat Pharma
        4.5.1 Chandra Bhagat Pharma Corporation Information
        4.5.2 Chandra Bhagat Pharma Description, Business Overview
        4.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Products Offered
        4.5.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2016-2021)
        4.5.5 Chandra Bhagat Pharma Drugs for Schistosomiasis Revenue by Product
        4.5.6 Chandra Bhagat Pharma Drugs for Schistosomiasis Revenue by Application
        4.5.7 Chandra Bhagat Pharma Drugs for Schistosomiasis Revenue by Geographic Area
        4.5.8 Chandra Bhagat Pharma Drugs for Schistosomiasis Revenue by Sales Channel
        4.5.9 Chandra Bhagat Pharma Recent Development
    4.6 Taj Pharmaceuticals
        4.6.1 Taj Pharmaceuticals Corporation Information
        4.6.2 Taj Pharmaceuticals Description, Business Overview
        4.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Products Offered
        4.6.4 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2016-2021)
        4.6.5 Taj Pharmaceuticals Drugs for Schistosomiasis Revenue by Product
        4.6.6 Taj Pharmaceuticals Drugs for Schistosomiasis Revenue by Application
        4.6.7 Taj Pharmaceuticals Drugs for Schistosomiasis Revenue by Geographic Area
        4.6.8 Taj Pharmaceuticals Recent Development

5 Breakdown Data by Type
    5.1 Global Drugs for Schistosomiasis Sales by Type (2016-2027)
        5.1.1 Global Drugs for Schistosomiasis Sales by Type (2016-2021)
        5.1.2 Global Drugs for Schistosomiasis Sales Forecast by Type (2022-2027)
        5.1.3 Global Drugs for Schistosomiasis Sales Market Share by Type (2016-2027)
    5.2 Global Drugs for Schistosomiasis Revenue Forecast by Type (2016-2027)
        5.2.1 Global Drugs for Schistosomiasis Revenue by Type (2016-2021)
        5.2.2 Global Drugs for Schistosomiasis Revenue Forecast by Type (2022-2027)
        5.2.3 Global Drugs for Schistosomiasis Revenue Market Share by Type (2016-2027)
    5.3 Drugs for Schistosomiasis Average Selling Price (ASP) by Type (2016-2027)

6 Breakdown Data by Application
    6.1 Global Drugs for Schistosomiasis Sales by Application (2016-2027)
        6.1.1 Global Drugs for Schistosomiasis Sales by Application (2016-2021)
        6.1.2 Global Drugs for Schistosomiasis Sales Forecast by Application (2022-2027)
        6.1.3 Global Drugs for Schistosomiasis Sales Market Share by Application (2016-2027)
    6.2 Global Drugs for Schistosomiasis Revenue Forecast by Application (2016-2027)
        6.2.1 Global Drugs for Schistosomiasis Revenue by Application (2016-2021)
        6.2.2 Global Drugs for Schistosomiasis Revenue Forecast by Application (2022-2027)
        6.2.3 Global Drugs for Schistosomiasis Revenue Market Share by Application (2016-2027)
    6.3 Drugs for Schistosomiasis Average Selling Price (ASP) by Application (2016-2027)

7 North America
    7.1 North America Drugs for Schistosomiasis Market Size YoY Growth 2016-2027
    7.2 North America Drugs for Schistosomiasis Market Facts & Figures by Country
        7.2.1 North America Drugs for Schistosomiasis Sales by Country (2016-2027)
        7.2.2 North America Drugs for Schistosomiasis Revenue by Country (2016-2027)
    7.3 North America Drugs for Schistosomiasis Sales by Type
    7.4 North America Drugs for Schistosomiasis Sales by Application

8 Asia-Pacific
    8.1 Asia-Pacific Drugs for Schistosomiasis Market Size YoY Growth 2016-2027
    8.2 Asia-Pacific Drugs for Schistosomiasis Market Facts & Figures by Region
        8.2.1 Asia-Pacific Drugs for Schistosomiasis Sales by Region (2016-2027)
        8.2.2 Asia-Pacific Drugs for Schistosomiasis Revenue by Region (2016-2027)
    8.3 Asia-Pacific Drugs for Schistosomiasis Sales by Type
    8.4 Asia-Pacific Drugs for Schistosomiasis Sales by Application

9 Europe
    9.1 Europe Drugs for Schistosomiasis Market Size YoY Growth 2016-2027
    9.2 Europe Drugs for Schistosomiasis Market Facts & Figures by Country
        9.2.1 Europe Drugs for Schistosomiasis Sales by Country (2016-2027)
        9.2.2 Europe Drugs for Schistosomiasis Revenue by Country (2016-2027)
    9.3 Europe Drugs for Schistosomiasis Sales by Type
    9.4 Europe Drugs for Schistosomiasis Sales by Application

10 Latin America
    10.1 Latin America Drugs for Schistosomiasis Market Size YoY Growth 2016-2027
    10.2 Latin America Drugs for Schistosomiasis Market Facts & Figures by Country
        10.2.1 Latin America Drugs for Schistosomiasis Sales by Country (2016-2027)
        10.2.2 Latin America Drugs for Schistosomiasis Revenue by Country (2016-2027)
    10.3 Latin America Drugs for Schistosomiasis Sales by Type
    10.4 Latin America Drugs for Schistosomiasis Sales by Application

11 Middle East and Africa
    11.1 Middle East and Africa Drugs for Schistosomiasis Market Size YoY Growth 2016-2027
    11.2 Middle East and Africa Drugs for Schistosomiasis Market Facts & Figures by Country
        11.2.1 Middle East and Africa Drugs for Schistosomiasis Sales by Country (2016-2027)
        11.2.2 Middle East and Africa Drugs for Schistosomiasis Revenue by Country (2016-2027)
    11.3 Middle East and Africa Drugs for Schistosomiasis Sales by Type
    11.4 Middle East and Africa Drugs for Schistosomiasis Sales by Application

12 Supply Chain and Sales Channel Analysis
    12.1 Drugs for Schistosomiasis Supply Chain Analysis
    12.2 Drugs for Schistosomiasis Key Raw Materials and Upstream Suppliers
    12.3 Drugs for Schistosomiasis Clients Analysis
    12.4 Drugs for Schistosomiasis Sales Channel and Sales Model Analysis
        12.4.1 Drugs for Schistosomiasis Distribution Channel Analysis: Indirect Sales VS Direct Sales
        12.4.2 Drugs for Schistosomiasis Distribution Channel Analysis: Online Sales VS Offline Sales
        12.4.3 Drugs for Schistosomiasis Distributors

13 Market Dynamics
    13.1 Drugs for Schistosomiasis Market Drivers
    13.2 Drugs for Schistosomiasis Market Opportunities
    13.3 Drugs for Schistosomiasis Market Challenges
    13.4 Drugs for Schistosomiasis Market Restraints
    13.5 Porter’s Five Forces Analysis

14 Research Findings and Conclusion

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Drugs for Schistosomiasis Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
    Table 2. Major Manufacturers of Praziquantel
    Table 3. Major Manufacturers of Oxamniquine
    Table 4. Major Manufacturers of Other
    Table 5. Global Drugs for Schistosomiasis Market Size Growth by Application (US$ Million): 2021 VS 2027
    Table 6. Global Drugs for Schistosomiasis Market Size by Region (US$ Million): 2021 VS 2027
    Table 7. Global Drugs for Schistosomiasis Sales by Region (2016-2021) & (M Units)
    Table 8. Global Drugs for Schistosomiasis Sales Forecast by Region (2022-2027) & (M Units)
    Table 9. Global Drugs for Schistosomiasis Revenue by Region (2016-2021) & (US$ Million)
    Table 10. Global Drugs for Schistosomiasis Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 11. Global Drugs for Schistosomiasis Sales by Manufacturer (2016-2021) & (M Units)
    Table 12. Global Drugs for Schistosomiasis Sales Share by Manufacturer (2016-2021)
    Table 13. Drugs for Schistosomiasis Revenue by Manufacturer (2016-2021) & (US$ Million)
    Table 14. Drugs for Schistosomiasis Revenue Share by Manufacturer (2016-2021)
    Table 15. Key Manufacturers Drugs for Schistosomiasis Price (2016-2021) & (USD/K Units)
    Table 16. Ranking of Global Top Drugs for Schistosomiasis Manufacturers by Revenue (US$ Million) in 2020
    Table 17. Global Drugs for Schistosomiasis Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 18. Global Drugs for Schistosomiasis by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drugs for Schistosomiasis as of 2020)
    Table 19. Drugs for Schistosomiasis Manufacturers Manufacturing Base Distribution and Headquarters
    Table 20. Manufacturers Drugs for Schistosomiasis Product Type
    Table 21. Date of International Manufacturers Enter into Drugs for Schistosomiasis Market
    Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 23. Shin Poong Corporation Information
    Table 24. Shin Poong Description and Business Overview
    Table 25. Shin Poong Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
    Table 26. Shin Poong Drugs for Schistosomiasis Product
    Table 27. Shin Poong Drugs for Schistosomiasis Revenue (US$ Million) and Market Share by Product
    Table 28. Shin Poong Drugs for Schistosomiasis Revenue (US$ Million) and Market Share by Application
    Table 29. Shin Poong Drugs for Schistosomiasis Revenue (US$ Million) and Market Share by Geographic Area
    Table 30. Shin Poong Drugs for Schistosomiasis Revenue (US$ Million) and Market Share by Sales Channel
    Table 31. Shin Poong Recent Development
    Table 32. Merck Corporation Information
    Table 33. Merck Description and Business Overview
    Table 34. Merck Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
    Table 35. Merck Drugs for Schistosomiasis Product
    Table 36. Merck Drugs for Schistosomiasis Revenue (US$ Million) and Market Share by Product
    Table 37. Merck Drugs for Schistosomiasis Revenue (US$ Million) and Market Share by Application
    Table 38. Merck Drugs for Schistosomiasis Revenue (US$ Million) and Market Share by Geographic Area
    Table 39. Merck Drugs for Schistosomiasis Revenue (US$ Million) and Market Share by Sales Channel
    Table 40. Merck Recent Development
    Table 41. Bayer Corporation Information
    Table 42. Bayer Description and Business Overview
    Table 43. Bayer Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
    Table 44. Bayer Drugs for Schistosomiasis Product
    Table 45. Bayer Drugs for Schistosomiasis Revenue (US$ Million) and Market Share by Product
    Table 46. Bayer Drugs for Schistosomiasis Revenue (US$ Million) and Market Share by Application
    Table 47. Bayer Drugs for Schistosomiasis Revenue (US$ Million) and Market Share by Geographic Area
    Table 48. Bayer Drugs for Schistosomiasis Revenue (US$ Million) and Market Share by Sales Channel
    Table 49. Bayer Recent Development
    Table 50. EIPICO Corporation Information
    Table 51. EIPICO Description and Business Overview
    Table 52. EIPICO Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
    Table 53. EIPICO Drugs for Schistosomiasis Product
    Table 54. EIPICO Drugs for Schistosomiasis Revenue (US$ Million) and Market Share by Product
    Table 55. EIPICO Drugs for Schistosomiasis Revenue (US$ Million) and Market Share by Application
    Table 56. EIPICO Drugs for Schistosomiasis Revenue (US$ Million) and Market Share by Geographic Area
    Table 57. EIPICO Drugs for Schistosomiasis Revenue (US$ Million) and Market Share by Sales Channel
    Table 58. EIPICO Recent Development
    Table 59. Chandra Bhagat Pharma Corporation Information
    Table 60. Chandra Bhagat Pharma Description and Business Overview
    Table 61. Chandra Bhagat Pharma Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
    Table 62. Chandra Bhagat Pharma Drugs for Schistosomiasis Product
    Table 63. Chandra Bhagat Pharma Drugs for Schistosomiasis Revenue (US$ Million) and Market Share by Product
    Table 64. Chandra Bhagat Pharma Drugs for Schistosomiasis Revenue (US$ Million) and Market Share by Application
    Table 65. Chandra Bhagat Pharma Drugs for Schistosomiasis Revenue (US$ Million) and Market Share by Geographic Area
    Table 66. Chandra Bhagat Pharma Drugs for Schistosomiasis Revenue (US$ Million) and Market Share by Sales Channel
    Table 67. Chandra Bhagat Pharma Recent Development
    Table 68. Taj Pharmaceuticals Corporation Information
    Table 69. Taj Pharmaceuticals Description and Business Overview
    Table 70. Taj Pharmaceuticals Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
    Table 71. Taj Pharmaceuticals Drugs for Schistosomiasis Product
    Table 72. Taj Pharmaceuticals Drugs for Schistosomiasis Revenue (US$ Million) and Market Share by Product
    Table 73. Taj Pharmaceuticals Drugs for Schistosomiasis Revenue (US$ Million) and Market Share by Application
    Table 74. Taj Pharmaceuticals Drugs for Schistosomiasis Revenue (US$ Million) and Market Share by Geographic Area
    Table 75. Taj Pharmaceuticals Recent Development
    Table 76. Global Drugs for Schistosomiasis Sales by Type (2016-2021) & (M Units)
    Table 77. Global Drugs for Schistosomiasis Sales Forecast by Type (2022-2027) & (M Units)
    Table 78. Global Drugs for Schistosomiasis Revenue by Type (2016-2021) & (US$ Million)
    Table 79. Global Drugs for Schistosomiasis Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 80. Global Drugs for Schistosomiasis Sales by Application (2016-2021) & (M Units)
    Table 81. Global Drugs for Schistosomiasis Sales Forecast by Application (2022-2027) & (M Units)
    Table 82. Global Drugs for Schistosomiasis Revenue by Application (2016-2021) & (US$ Million)
    Table 83. Global Drugs for Schistosomiasis Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 84. North America Drugs for Schistosomiasis Sales by Country (2016-2021) & (M Units)
    Table 85. North America Drugs for Schistosomiasis Sales by Country (2022-2027) & (M Units)
    Table 86. North America Drugs for Schistosomiasis Revenue by Country (2016-2021) & (US$ Million)
    Table 87. North America Drugs for Schistosomiasis Revenue by Country (2022-2027) & (US$ Million)
    Table 88. North America Drugs for Schistosomiasis Sales by Type (2016-2021) & (M Units)
    Table 89. North America Drugs for Schistosomiasis Sales by Application (2016-2021) & (M Units)
    Table 90. Asia-Pacific Drugs for Schistosomiasis Sales by Region (2016-2021) & (M Units)
    Table 91. Asia-Pacific Drugs for Schistosomiasis Sales by Region (2022-2027) & (M Units)
    Table 92. Asia-Pacific Drugs for Schistosomiasis Revenue by Region (2016-2027) & (US$ Million)
    Table 93. Asia-Pacific Drugs for Schistosomiasis Revenue by Region (2022-2027) & (US$ Million)
    Table 94. Asia-Pacific Drugs for Schistosomiasis Sales by Type (2016-2021) & (M Units)
    Table 95. Asia-Pacific Drugs for Schistosomiasis Sales by Application (2016-2021) & (M Units)
    Table 96. Europe Drugs for Schistosomiasis Sales by Country (2016-2021) & (M Units)
    Table 97. Europe Drugs for Schistosomiasis Sales by Country (2022-2027) & (M Units)
    Table 98. Europe Drugs for Schistosomiasis Revenue by Country (2016-2021) & (US$ Million)
    Table 99. Europe Drugs for Schistosomiasis Revenue by Country (2022-2027) & (US$ Million)
    Table 100. Europe Drugs for Schistosomiasis Sales by Type (2016-2021) & (M Units)
    Table 101. Europe Drugs for Schistosomiasis Sales by Application (2016-2021) & (M Units)
    Table 102. Latin America Drugs for Schistosomiasis Sales by Country (2016-2021) & (M Units)
    Table 103. Latin America Drugs for Schistosomiasis Sales by Country (2022-2027) & (M Units)
    Table 104. Latin America Drugs for Schistosomiasis Revenue by Country (2016-2021) & (US$ Million)
    Table 105. Latin America Drugs for Schistosomiasis Revenue by Country (2022-2027) & (US$ Million)
    Table 106. Latin America Drugs for Schistosomiasis Sales by Type (2016-2021) & (M Units)
    Table 107. Latin America Drugs for Schistosomiasis Sales by Application (2016-2021) & (M Units)
    Table 108. Middle East and Africa Drugs for Schistosomiasis Sales by Country (2016-2021) & (M Units)
    Table 109. Middle East and Africa Drugs for Schistosomiasis Sales by Country (2022-2027) & (M Units)
    Table 110. Middle East and Africa Drugs for Schistosomiasis Revenue by Country (2016-2021) & (US$ Million)
    Table 111. Middle East and Africa Drugs for Schistosomiasis Revenue by Country (2022-2027) & (US$ Million)
    Table 112. Middle East and Africa Drugs for Schistosomiasis Sales by Type (2016-2021) & (M Units)
    Table 113. Middle East and Africa Drugs for Schistosomiasis Sales by Application (2016-2021) & (M Units)
    Table 114. Drugs for Schistosomiasis Key Raw Materials, Industry Status and Trend
    Table 115. Drugs for Schistosomiasis Key Raw Materials and Upstream Suppliers
    Table 116. Drugs for Schistosomiasis Clients Status and Trend
    Table 117. Drugs for Schistosomiasis Typical Clients
    Table 118. Drugs for Schistosomiasis Distributors
    Table 119. Key Drivers: Impact Analysis (2022-2027)
    Table 120. Drugs for Schistosomiasis Market Drivers
    Table 121. Drugs for Schistosomiasis Market Opportunities
    Table 122. Drugs for Schistosomiasis Market Challenges
    Table 123. Drugs for Schistosomiasis Market Restraints
    Table 124. Drugs for Schistosomiasis Porter’s Five Forces Analysis
    Table 125. Research Programs/Design for This Report
    Table 126. Key Data Information from Secondary Sources
    Table 127. Key Data Information from Primary Sources
List of Figures
    Figure 1. Drugs for Schistosomiasis Product Picture
    Figure 2. Global Drugs for Schistosomiasis Sales Market Share by Type in 2021 & 2027
    Figure 3. Praziquantel Product Picture
    Figure 4. Oxamniquine Product Picture
    Figure 5. Other Product Picture
    Figure 6. Global Drugs for Schistosomiasis Sales Market Share by Application in 2021 & 2027
    Figure 7. S. haematobium Examples
    Figure 8. S. mansoni Examples
    Figure 9. S. japonicum Examples
    Figure 10. S. mekongi Examples
    Figure 11. S. intercalatum Examples
    Figure 12. Drugs for Schistosomiasis Report Years Considered
    Figure 13. Global Drugs for Schistosomiasis Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Drugs for Schistosomiasis Market Size 2016-2027 (US$ Million)
    Figure 15. Global Drugs for Schistosomiasis Sales 2016-2027 (K Units)
    Figure 16. Global Drugs for Schistosomiasis Market Size Market Share by Region: 2021 Versus 2027
    Figure 17. Global Drugs for Schistosomiasis Sales Market Share Forecast by Region (2016-2027)
    Figure 18. Global Drugs for Schistosomiasis Revenue Market Share by Region (2016-2027)
    Figure 19. Global Drugs for Schistosomiasis Sales Share by Manufacturer in 2020
    Figure 20. Drugs for Schistosomiasis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 21. Global Drugs for Schistosomiasis Sales Market Share Forecast by Type (2016-2027)
    Figure 22. Global Drugs for Schistosomiasis Revenue Market Share Forecast by Type (2016-2027)
    Figure 23. Drugs for Schistosomiasis Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
    Figure 24. Global Drugs for Schistosomiasis Sales Market Share Forecast by Application (2016-2027)
    Figure 25. Global Drugs for Schistosomiasis Revenue Market Share Forecast by Application (2016-2027)
    Figure 26. Drugs for Schistosomiasis Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
    Figure 27. North America Drugs for Schistosomiasis Revenue 2016-2027 (US$ Million)
    Figure 28. North America Drugs for Schistosomiasis Sales Market Share by Type (2016-2021)
    Figure 29. North America Drugs for Schistosomiasis Sales Market Share by Application (2016-2021)
    Figure 30. Asia-Pacific Drugs for Schistosomiasis Revenue 2016-2027 (US$ Million)
    Figure 31. Asia-Pacific Drugs for Schistosomiasis Sales Market Share by Region (2016-2027)
    Figure 32. Asia-Pacific Drugs for Schistosomiasis Revenue Market Share by Region (2016-2027)
    Figure 33. Asia-Pacific Drugs for Schistosomiasis Sales Market Share by Type (2016-2021)
    Figure 34. Asia-Pacific Drugs for Schistosomiasis Sales Market Share by Application (2016-2021)
    Figure 35. Europe Drugs for Schistosomiasis Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 36. Europe Drugs for Schistosomiasis Sales Market Share by Country (2016-2027)
    Figure 37. Europe Drugs for Schistosomiasis Revenue Market Share by Country (2016-2027)
    Figure 38. Europe Drugs for Schistosomiasis Sales Market Share by Type (2016-2021)
    Figure 39. Europe Drugs for Schistosomiasis Sales Market Share by Application (2016-2021)
    Figure 40. Latin America Drugs for Schistosomiasis Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 41. Latin America Drugs for Schistosomiasis Sales Market Share by Country (2016-2027)
    Figure 42. Latin America Drugs for Schistosomiasis Revenue Market Share by Country (2016-2021)
    Figure 43. Latin America Drugs for Schistosomiasis Sales Market Share by Type (2016-2021)
    Figure 44. Latin America Drugs for Schistosomiasis Sales Market Share by Application (2016-2021)
    Figure 45. Middle East and Africa Drugs for Schistosomiasis Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 46. Middle East and Africa Drugs for Schistosomiasis Sales Market Share by Country (2016-2027)
    Figure 47. Middle East and Africa Drugs for Schistosomiasis Revenue Market Share by Country (2016-2027)
    Figure 48. Middle East and Africa Drugs for Schistosomiasis Sales Market Share by Type (2016-2021)
    Figure 49. Middle East and Africa Drugs for Schistosomiasis Sales Market Share by Application (2016-2021)
    Figure 50. Drugs for Schistosomiasis Supply Chain (Upstream and Downstream Market)
    Figure 51. Global Production Market Share of Drugs for Schistosomiasis Raw Materials by Region in 2020
    Figure 52. Drugs for Schistosomiasis Distribution Channels
    Figure 53. Global Drugs for Schistosomiasis Percentage 2016-2027: Indirect Sales VS Direct Sales
    Figure 54. Global Drugs for Schistosomiasis Percentage 2016-2027: Online Sales VS Offline Sales
    Figure 55. Porter's Five Forces Analysis
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
Frequently Asked Questions
Drugs for Schistosomiasis report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Drugs for Schistosomiasis report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Drugs for Schistosomiasis report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Hoist

A hoist is a mechanical device for lifting material, typically consisting of a rope or chain arou ... Read More